Chemed Corporation (CHE) Institutional Ownership & Insider Trading

529 institutions reported holding Chemed Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 13 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CHEChemed CorporationFollow CHE — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 6.7B
P/E TTM: 25.8
Dividend yield: 0.5%
52-week: —
Next earnings: 27 Oct, in 3 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

529 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +0.2%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	529	14	+0.2%	168	82	180	52
Mar 26	484	13	-4.0%	159	37	179	58
Dec 25	510	14	-3.3%	147	44	206	56
Sep 25	510	14	+4.2%	173	50	177	69
Jun 25	531	14	+0.5%	185	52	168	61
Mar 25	545	14	-1.1%	158	74	174	45
Dec 24	523	14	-4.3%	138	36	190	46
Sep 24	516	14	-5.2%	163	48	146	43

Chemed Corporation — questions

Who owns Chemed Corporation stock?: 529 institutions reported Chemed Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (11.4%), AQR CAPITAL MANAGEMENT LLC (7.4%), VANGUARD PORTFOLIO MANAGEMENT LLC (6.0%).
Are Chemed Corporation insiders buying or selling?: 13 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Chemed Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.